Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris

Last updated: November 30, 2022
Sponsor: Pak Emirates Military Hospital
Overall Status: Completed

Phase

3

Condition

Rash

Acne

Inflammatory Comedones

Treatment

N/A

Clinical Study ID

NCT05629468
A/28/EC/337/2021
  • Ages 15-35
  • All Genders

Study Summary

the goal of this clinical trial is to measure the efficacy of probiotics for treatment of acne vulgaris, to compare it with azithromycin and to measure the synergistic effect of azithromycin and probiotics for treatment of acne vulgaris

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed Patients of Mild and Moderate acne
  • Aged between 15 and 35 years

Exclusion

Exclusion Criteria:

  • Severe acne or any systemic inflammatory disease
  • Other oral treatment for acne
  • Allergic to any drug being used in the study
  • Pregnancy
  • PCOs
  • Any drug which can interact with azithromycin

Study Design

Total Participants: 75
Study Start date:
October 15, 2021
Estimated Completion Date:
August 31, 2022

Study Description

this study aims to answer this research question: in patients of acne vulgaris, is use of probiotics as efficacious as azithromycin in treating acne lesions & improving quality of life? total 75 patients were divided into 3 groups. group A received azithromycin, group B received probiotics and group C received both drugs. a topical cream was also advised to all groups. outcome was measured as reduction in total lesion count and improvement in patients' quality of life via reduction in Dermatology Life Quality Index score.

Connect with a study center

  • PEMH

    Rawalpindi, Punjab 46000
    Pakistan

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.